Risk Factors for Penile Prosthetic Infection

1996 ◽  
Vol 156 (2) ◽  
pp. 402-404 ◽  
Author(s):  
Jonathan P. Jarow
Keyword(s):  
Risk Factors ◽  
Prosthetic Infection

Risk factors for urological prosthetic infection

1997 ◽  
Vol 64 (1) ◽  
pp. 65-69 ◽  
Author(s):  
P. Fortunato ◽  
M. Schettini ◽  
M. Gallucci
Keyword(s):  
Risk Factors ◽  
Infection Rate ◽  
Artificial Urinary Sphincter ◽  
Prosthetic Infection ◽  
Penile Prostheses ◽  
Urinary Sphincter ◽  
Significant Difference ◽  
The Mean ◽  
Revision Operations

We reviewed our experience of 91 procedures for implant and revision of urological prostheses from 1989 to 1996. The aim of the study was to determine the risk factors for urological prostheses. The procedures consisted of 48 implants of artificial urinary sphincters AMS 800 (35 primary implants and 13 revisions) and 43 penile prostheses (40 primary implants and 3 revisions). Simultaneous penile reconstruction was performed in 5 cases. The mean follow-up was 2 years (range 1-6 years) for artificial urinary sphincter and 1.8 years (range 1-4) for penile prostheses. Infection occurred in 7 cases (4 urinary sphincter and 3 penile prostheses). The infection rate after primary uncomplicated implant of AMS 800 was 8.5% compared to 7.6% for revision procedures (p=n.s.). The infection rate after primary implant of penile prostheses was 5% compared to 33% for revision procedures. There was a similar significant difference between the penile prostheses implant group with reconstruction of the corpora (2 out 5 patients) and the primary uncomplicated implant group (p=0.001). The risk of infection is significantly greater when penile reconstruction is required and is associated with revision operations.

Risk factors for penile prosthetic infection

2003 ◽  
Vol 35 (2) ◽  
pp. 209-213 ◽  
Author(s):  
M. Çakan ◽  
F. Demirel ◽  
O. Karabacak ◽  
F. Yalçınkaya ◽  
U. Altuğ
Keyword(s):  
Risk Factors ◽  
Prosthetic Infection

Elevated level of circulatory sTLT1 induces inflammation through SYK/MEK/ERK signalling in coronary artery disease

2019 ◽  
Vol 133 (22) ◽  
pp. 2283-2299
Author(s):  
Apabrita Ayan Das ◽  
Devasmita Chakravarty ◽  
Debmalya Bhunia ◽  
Surajit Ghosh ◽  
Prakash C. Mandal ◽  
...  
Keyword(s):  
Risk Factors ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Chronic Inflammation ◽  
Ex Vivo ◽  
Human Subjects ◽  
Critical Role ◽  
Atherosclerotic Cardiovascular Disease ◽  
Tnf Α ◽  
Artery Disease

Abstract The role of inflammation in all phases of atherosclerotic process is well established and soluble TREM-like transcript 1 (sTLT1) is reported to be associated with chronic inflammation. Yet, no information is available about the involvement of sTLT1 in atherosclerotic cardiovascular disease. Present study was undertaken to determine the pathophysiological significance of sTLT1 in atherosclerosis by employing an observational study on human subjects (n=117) followed by experiments in human macrophages and atherosclerotic apolipoprotein E (apoE)−/− mice. Plasma level of sTLT1 was found to be significantly (P<0.05) higher in clinical (2342 ± 184 pg/ml) and subclinical cases (1773 ± 118 pg/ml) than healthy controls (461 ± 57 pg/ml). Moreover, statistical analyses further indicated that sTLT1 was not only associated with common risk factors for Coronary Artery Disease (CAD) in both clinical and subclinical groups but also strongly correlated with disease severity. Ex vivo studies on macrophages showed that sTLT1 interacts with Fcɣ receptor I (FcɣRI) to activate spleen tyrosine kinase (SYK)-mediated downstream MAP kinase signalling cascade to activate nuclear factor-κ B (NF-kB). Activation of NF-kB induces secretion of tumour necrosis factor-α (TNF-α) from macrophage cells that plays pivotal role in governing the persistence of chronic inflammation. Atherosclerotic apoE−/− mice also showed high levels of sTLT1 and TNF-α in nearly occluded aortic stage indicating the contribution of sTLT1 in inflammation. Our results clearly demonstrate that sTLT1 is clinically related to the risk factors of CAD. We also showed that binding of sTLT1 with macrophage membrane receptor, FcɣR1 initiates inflammatory signals in macrophages suggesting its critical role in thrombus development and atherosclerosis.

The Preschool Stuttering Screen for Health Care Professionals

2011 ◽  
Vol 21 (2) ◽  
pp. 59-62
Author(s):  
Joseph Donaher ◽  
Christina Deery ◽  
Sarah Vogel
Keyword(s):  
Risk Factors ◽  
Health Care ◽  
Differential Diagnosis ◽  
Preschool Children ◽  
Health Care Professionals ◽  
Healthcare Professionals ◽  
Evidence Based ◽  
Developmental Profile

Healthcare professionals require a thorough understanding of stuttering since they frequently play an important role in the identification and differential diagnosis of stuttering for preschool children. This paper introduces The Preschool Stuttering Screen for Healthcare Professionals (PSSHP) which highlights risk factors identified in the literature as being associated with persistent stuttering. By integrating the results of the checklist with a child’s developmental profile, healthcare professionals can make better-informed, evidence-based decisions for their patients.

Clinical Response to Questions Regarding Outcomes and Therapy Efficacy

2010 ◽  
Vol 20 (3) ◽  
pp. 76-83 ◽  
Author(s):  
Joseph Donaher ◽  
Tom Gurrister ◽  
Irving Wollman ◽  
Tim Mackesey ◽  
Michelle L. Burnett
Keyword(s):  
Risk Factors ◽  
Clinical Response ◽  
Speech Language Pathologists ◽  
Specific Therapy ◽  
Therapy Efficacy ◽  
Therapy Program ◽  
Adults Who Stutter ◽  
Cure Rates

Parents of children who stutter and adults who stutter frequently ask speech-language pathologists to predict whether or not therapy will work. Even though research has explored risk-factors related to persistent stuttering, there remains no way to determine how an individual will react to a specific therapy program. This paper presents various clinicians’answers to the question, “What do you tell parents or adults who stutter when they ask about cure rates, outcomes, and therapy efficacy?”

Sign in / Sign up

Export Citation Format

Share Document